Law360 | Clinical Biopharma Sienna OK’d to Sell IP in Ch. 11

Alston & Bird won a precedential ruling from the U.S. Court of Appeals for the Federal Circuit on behalf of General Hospital Corporation and licensee Sebacia Inc., in which the court vacated a decision by the Patent Trial and Appeal Board (PTAB) to dismiss a patent interference proceeding request by GHC against Sienna Biopharmaceuticals, Inc.